© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
171371 |
As an accredited 3-Bromo-2,6-Difluorobenzaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-2,6-Difluorobenzaldehyde prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Some compounds stick out in a laboratory for their reliability and versatility, and 3-Bromo-2,6-Difluorobenzaldehyde easily falls into that group. With the steady rise in demand for specialized intermediates in pharmaceuticals and materials research, this molecule has found a dedicated niche. Chemists working on new synthesis routes or trying to develop unique molecular architectures pick it for its smart balance between reactivity and stability. The presence of both bromine and fluorine atoms on a benzaldehyde backbone gives it a rare set of reaction pathways, many of which are not easy to achieve with more common aldehydes.
The structure—bearing bromine at the 3-position, with two fluorines snugly sitting at the 2,6-positions—lets this compound toggle between nucleophilic and electrophilic behavior depending on reaction partners. Most practitioners in organic chemistry have dealt with single-fluorine compounds, but double-fluorinated aromatics have started drawing more interest thanks to their unique electronic effects. This molecule’s particular pattern makes it ready for cross-coupling reactions such as Suzuki or Buchwald-Hartwig, where chemists need predictable reactivity and functional group tolerance.
The biggest selling point for 3-Bromo-2,6-Difluorobenzaldehyde lies in its combination of three reactive sites. The aldehyde group brings classic reactivity, making room for condensation, reductive amination, or Wittig reactions, while the bromine invites palladium-catalyzed coupling. Fluorine, though less obvious, exerts effects on reactivity and metabolic stability that few other substituents can match. Medicinal chemists lean on fluorinated aromatics to tweak drug-like properties, often boosting bioavailability or changing the way a drug behaves in the body. In the lab, the difference between success and stagnation can depend on having the right intermediate; with this compound, scientists can take their molecule down different synthetic paths without swapping out their building blocks.
It's not rare to see a research team start with a bromobenzaldehyde and then need to tack on a fluorine at just the right spot after the fact. By using 3-Bromo-2,6-Difluorobenzaldehyde as a starting point, the fiddly stepwise addition of fluorines can get skipped, saving a substantial amount of time and cost. The direct access to a difluorinated, brominated aldehyde makes this product not just another option on a shelf, but a key facilitator for projects racing against the clock or facing limited resources.
On paper, the model C8H3BrF2O tells you most of what you need, but the story runs deeper. Purity matters more than most realize; the standard offering of this compound hovers at above 98%. Impurities may sound like a technical detail, but a trace of the wrong byproduct can throw off multi-step syntheses or skew analytical readings. High purity in 3-Bromo-2,6-Difluorobenzaldehyde ensures smoother process validation and fewer surprises down the line.
Specifications usually focus on melting point and spectral data, yet every synthetic chemist knows that good solubility and handling ease push this chemical into the realm of practical favorites. In daily work, the powdery, off-white solid comes out of the bottle without any fuss, and dissolves quickly in most common solvents like dichloromethane, ethyl acetate, and even some alcohols. That small detail about handling cuts down on lost time, and stories of frustrating, stubborn residues quickly become a thing of the past.
Ask chemists what makes 3-Bromo-2,6-Difluorobenzaldehyde stand out from more typical benzaldehydes or even competing difluorinated compounds, and one answer crops up time and again: control. Synthesizers work with a broad spectrum of brominated and fluorinated aromatics, but getting strategic placement of both substituents rarely comes this neatly. This compound unlocks transformations that would take multiple steps starting from something like 2,6-difluorobenzaldehyde or 3-bromobenzaldehyde alone.
Other intermediates may check one or two boxes, but they often call for further modification—a drain on consumables, time, and sometimes even yield. By having bromine and both fluorines already in place, projects can jump directly to advanced coupling reactions. That’s a competitive difference in preclinical drug discovery or materials science, where delays tend to snowball as the project timeline unfolds.
The versatility of this molecule turns up across several sectors. In the pharmaceutical world, 3-Bromo-2,6-Difluorobenzaldehyde can act as a gateway for building up core structures used in kinase inhibitors and antivirals. The double fluorine effect has even shown up in agrochemical discovery and dye chemistry. Fluorinated aromatics tend to behave differently in biological settings, oftentimes showing improvements over their non-fluorinated analogs when it comes to metabolic resistance or protein binding.
Materials researchers have started exploring such compounds in the design of new polymers and coatings that demand both stability and fine-tuned electronic properties. Devices like organic light-emitting diodes (OLEDs) and specialty sensors lean heavily on a supply of precision fluorinated and brominated aromatics. These applications aren’t just on the cutting edge of research—they’re already showing up in nascent commercial products.
Every synthetic chemist working with organofluorines knows the practical barriers. Many fluorinated aromatics attract a higher price tag, both because of raw material cost and the complexity of manufacturing. Historically, selective fluorination at the 2,6-positions meant handling tough reagents, high pressures, or catalytic systems that not every lab could deploy safely. That background makes the ready availability of a well-characterized, highly pure 3-Bromo-2,6-Difluorobenzaldehyde all the more attractive.
The factory production of this compound usually follows reliable routes that keep byproducts minimal. It’s not just a question of chemistry—the scale and safety that experienced manufacturers bring to the process provide a peace of mind. Purity isn’t just a technical spec, it’s the difference between a batch that advances clinical timelines or one that sits on a shelf, unsuited for regulatory review or pilot-scale scale-up.
In the past, only major pharma companies and elite research teams could afford continued access to industry-grade intermediates like this. The market started shifting as smaller biotech startups began punching above their weight by accessing smarter synthetic building blocks. With 3-Bromo-2,6-Difluorobenzaldehyde now broadly available through reliable suppliers, innovators and academic groups can push big ideas forward without logistical drag.
Taking one example, medicinal chemistry students at my own university have shared how compounds like this change the way they think about retrosynthetic planning. Instead of spending weeks optimizing steps to install both bromine and fluorines sequentially, they can leapfrog that entire phase and focus energy on novel transformations. The knock-on effect for talent development is obvious: more time spent learning serious synthesis, less frustration with slow or unpredictable reactions at the substrate preparation stage.
Handling complex intermediates has its own learning curve. The chemical industry’s push for better data transparency and stricter safety protocols has filtered into the selection of reagents like 3-Bromo-2,6-Difluorobenzaldehyde. Proper use not only reduces hazard but also leads to better experimental outcomes. In my own experience, common-sense labeling, up-to-date safety sheets, and clear communication between purchasing and lab staff have helped lower risks. When storing and disposing, chemists think ahead to compatibility with solvents and containers; certain organofluorines do well in glass, but need separation from reactive metals or open flame.
Education plays a critical role here. Many institutions run short training sessions on the safe use of halogenated and fluorinated aromatics, emphasizing spill response and fume hood procedures. Staying ahead of regulatory changes means fewer surprises when scaling up, both in academic labs and pilot-scale startup facilities. That’s especially true with intermediates containing multiple reactive halogens. For anyone entering the field or teaching newcomers, it pays to treat these compounds not just as reagents, but as entry points to best laboratory practices.
Green chemistry has started shaping how advanced intermediates get made and used. Researchers across both academia and industry are paying more attention to waste reduction, atom economy, and solvent choice. Some manufacturers now push for lower-energy processes to prepare 3-Bromo-2,6-Difluorobenzaldehyde. I’ve seen facilities begin shifting toward continuous flow synthesis and using recyclable catalysts, both aiming to cut down on hazardous byproducts and limit exposure risks.
Those working in discovery research appreciate not just the molecule itself, but the process transparency that comes with modern supply chains. As more users ask for batch-specific data—NMR spectra, chromatograms, detailed impurity profiles—the trust in product consistency grows. The days of guessing at lot-to-lot variability are going away, pushing up the standard of experimental design and data reproducibility.
Demand for halogenated and fluorinated aldehydes plays out differently around the globe. In North America and Europe, tighter environmental and workplace regulations often force manufacturers to innovate faster, delivering the same products using greener methods or with reduced solvent waste. Asian research outfits, especially those working in pharmaceuticals and agricultural chemicals, drive volume and price competition, ensuring more labs can access these specialty intermediates at a manageable cost.
Anecdotes from global collaborators paint the same picture: more teams can now experiment with advanced building blocks without calling in custom syntheses or risking uncharacterized reagents. That wider access shortens the development pipeline, letting breakthroughs move quickly from bench to clinical or pilot scale.
Growing interest in complex aromatic scaffolds fuels a new generation of synthetic innovations. The clever use of intermediates with built-in functionality, like 3-Bromo-2,6-Difluorobenzaldehyde, helps bypass costly and hazardous late-stage modifications. That’s become especially important as drug targets grow in complexity and personalized medicine requires more unique compound libraries.
The domino effect is real: give a synthetic team easier access to sophisticated intermediates, and those researchers turn around faster, produce cleaner data, and unlock new ideas. Labs with the confidence to order and handle such reagents experiment more broadly, sometimes moving knowledge forward by leaps rather than increments.
Advanced intermediates like this have begun closing gaps in supply chains, making it easier for innovation-driven companies to stick to aggressive development schedules. Delays linked to unavailable or variable-quality intermediates become less common; chemists can spend less time troubleshooting and more time exploring new chemistry. In my work consulting for startups, the biggest difference follows the introduction of robust intermediate supplies—suddenly project teams no longer pause for months to backtrack or redesign synthesis plans.
Vendors now compete not just on price, but also on stability of supply and transparency about their manufacturing routes. As these standards become the norm, universities and small companies find themselves on a more even footing with major industry players. Standardization—backed up by reliable certificates of analysis and real-time technical support—makes it easier to scale up discoveries or comply with evolving regulatory frameworks.
Modern research success pivots on selecting intermediates with the right pedigree. While cost and lead time stay important, the underlying guarantee of quality can’t get overlooked. For sensitive synthesis, even a minor deviation in purity or material consistency undermines months of planning. That’s where 3-Bromo-2,6-Difluorobenzaldehyde separates itself from crowd favorites like monofluorobenzaldehydes or basic brominated aromatics.
Researchers now rely less on vendor reputation alone and more on direct verification. Detailed spectra, transparent batch histories, and even user reviews grow more common in the procurement pipeline. That attention to verification serves as a necessary backstop in markets awash with lower-grade or poorly characterized products. In my own lab time, checking spec sheets often turned up discrepancies; having access to well-backed products kept down reruns and wasted effort.
Looking ahead, the space for small yet clever molecules keeps expanding. The jump from basic research to applied science narrows as more people have the means to get their hands on reliable, multifunctional intermediates. If the past decade revolved around simple one-function reagents, the next wave focuses on compounds like 3-Bromo-2,6-Difluorobenzaldehyde, which come ready for multi-dimensional exploration.
Tools for tracking provenance and quality have also become part of the conversation. Supply chain traceability feeds directly into regulatory confidence, publication reliability, and—ultimately—public trust. As global standards align through harmonized paperwork and inter-laboratory comparisons, the real winners are those researchers who can move quickly from hypothesis to molecule with fewer false starts.
Smart scientists lean on compounds that give them more than one path to progress. 3-Bromo-2,6-Difluorobenzaldehyde isn’t just another bottle on the shelf. It opens doors for new molecular designs, lets research teams bypass cumbersome modifications, and embodies the ongoing shift toward smarter, cleaner, and more collaborative science.
It’s easy to overlook the value of these specialized intermediates until a project depends on them. Once teams see the benefits—fewer purification headaches, faster reaction planning, more reliable data—they treat such products as go-to resources rather than occasional indulgences. Direct experience bears it out: every time a project moved faster with this material, other colleagues took note and adjusted their own sourcing strategies.
Everyone talks about speed and agility in research, yet these qualities only matter when foundational reagents align with scientific goals. The story of 3-Bromo-2,6-Difluorobenzaldehyde overlaps with the broader push for open, trustworthy, and reproducible science. By demanding higher standards from suppliers and using more sophisticated building blocks, researchers help lift the whole industry.
Ongoing collaboration between manufacturers, scientists, and regulatory bodies both supports safe use and raises collective confidence. Whether the task is drug discovery, materials testing, or process optimization, access to quality intermediates can be the decisive factor that propels a small idea into a tangible result. Compounds like this play a quiet, foundational role in that journey.
No single compound makes or breaks chemical innovation, but the adoption of smarter intermediates nudges the entire field forward. With 3-Bromo-2,6-Difluorobenzaldehyde bringing streamlined synthesis and broad reaction flexibility, research teams can think bigger and move faster. From hands-on lab experience to strategic planning in R&D, the choice of building blocks shapes every step of discovery and invention. By focusing on quality, reactivity, and responsible use, chemists stake their claim in a future marked by sharper science and better outcomes.
